Dolonil 50 mg (Capsule)
Medicine Details
Category | Details |
---|---|
Generic | Tramadol hydrochloride |
Company | Acme laboratories ltd |
Also available as |
Indications
- Postoperative pain
- Colic and spastic pain
- Cancer pain
- Joint pain
- Neck and back pain
- Pain associated with osteoporosis
Pharmacology
Tramadol is a centrally acting synthetic analgesic compound. It inhibits the reuptake of neurotransmitters- serotonin and noradrenaline. It modifies the transmission of pain impulses by activating both descending serotonergic pathways and noradrenergic pathways involved in analgesia.
Dosage & Administration
- Capsule or Tablet: Usual doses are 50 to 100 mg every four to six hours. Total daily dosage by mouth should not exceed 400 mg.
- Sustained Release Capsule or Tablet: One SR capsule or tablet every 12 hours. Total daily dosage by mouth should not exceed 400 mg.
- Injection: A dose of 50-100 mg may be given every 4 to 6 hours by intramuscular or by intravenous infusion. Total daily dose should not exceed 600 mg.
- Suppository: For adults usual dose is 100 mg Tramadol Hydrochloride 6 hourly. Total daily dose varies.
Interaction
In general, physician need not be concerned about drugs interacting with Dolonil. Concomitant administration of carbamazepine with Dolonil causes a significant increase in Dolonil metabolism.
Contraindications
Tramadol is contraindicated in persons having hypersensitivity to this drug, and acute intoxication with certain substances.
Side Effects
- Dizziness/vertigo
- Nausea
- Constipation
- Headache
- Somnolence
- Vomiting
- Pruritus
- CNS stimulation
- Asthenia
- Sweating
- Dyspepsia
- Dry mouth
- Diarrhea
- Malaise
- Allergic reaction
- Weight loss
- Vasodilatation
- Palpitations
- Abdominal pain
- Anorexia
- Flatulence
- GI bleeding
- Hepatitis
- Stomatitis
Pregnancy & Lactation
Safe use of Tramadol in pregnancy has not been established. Tramadol should not be administered during breastfeeding.
Precautions & Warnings
- Respiratory depression: Tramadol should be administered cautiously in patients at risk for respiratory depression.
- Opioid dependence: Dolonil is not recommended for patients who are dependent on opioids.
- Concomitant CNS depressants: Dolonil should be used with caution and in reduced dosages when administering to patients receiving CNS depressants.
- Concomitant MAO inhibitors: Dolonil should be used with great caution in patients taking MAO inhibitors.
- Increased intracranial pressure or head injury: Dolonil should be used with caution in patients with increased intracranial pressure or head injury.
Use in Special Populations
- In children from the age of 1 year Dolonil can be given in a dose of 1-2 mg/kg body weight.
- Suppository (100 mg Dolonil) should not be administered in children and adolescents below the age of 14 years.
- Dolonil 100 mg SR Capsules have not been studied in children.
Therapeutic Class
Opioid analgesics
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Related Brands
- Dolonil 100 mg/2 ml (IM/IV Injection) - acme-laboratories-ltd
- Winpain 50 mg (Capsule) - incepta-pharmaceuticals-ltd
- Tramavir 100 mg (Tablet) - virgo-pharmaceuticals-ltd
- Utramal 50 mg (Capsule) - unimed-unihealth-pharmaceuticals-ltd
- Utramal 100 mg/2 ml (IM/IV Injection) - unimed-unihealth-pharmaceuticals-ltd